Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

March 17, 2025
Taiho Pharmaceutical

Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech
March 14, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical is Expanding “Local Production and Local Recycling” of PET Bottle Initiatives in Cooperation with Local Communities Agreement Signed with the Saga Eastern Environmental Facilities Association for Horizontal Recycling of PET Bottles
March 13, 2025
Otsuka Pharmaceutical

Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older
March 13, 2025
Otsuka Foods

Otsuka Foods to Introduce 100% Recycled PET Bottles for JAVA TEA Lessening Environmental Impact by Reducing CO₂ Emissions to Contribute to a Sustainable Society
March 13, 2025
Otsuka Holdings

Publication of Otsuka Health Comic Library “What are Medicines for?” Celebrating 35 years of helping to boost child health literacy
March 12, 2025
Otsuka Holdings

Otsuka Holdings Receives Award for Excellence for the First Time at the NIKKEI Integrated Report Award 2024
March 3, 2025
Otsuka Pharmaceutical

SOYJOY Black Sesame A Bold Sesame Experience with a Delightful Popping Texture and Roasted Aroma
March 3, 2025
Otsuka Pharmaceutical

HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Is Now on Sale - Insurance coverage begins on March 1, 2025 -
February 26, 2025
Otsuka HoldingsTaiho Pharmaceutical

Solar Power Generation Facility Launched at Taiho Pharmaceutical’s Kitajima Plant to Accelerate Carbon Neutrality Initiatives
February 26, 2025
Otsuka Foods

Otsuka Foods to Release 100kcal “My Size Plus Support, 1g Salt Chuka-don” and “100kcal My Size Plus Support, 1g Salt Mabo-don” Two Delicious Products Designed to Help Solve Japan’s Health Issue of Too Much Dietary Salt Available at Drugstores, Pharmacies and Other Outlets Nationwide Starting March 17, 2025
February 20, 2025
Otsuka Pharmaceutical

Otsuka Sponsor TOKYO MARATHON 2025 Supporting the Conditioning of Runners Worldwide with the Global Brand POCARI SWEAT
February 19, 2025
Otsuka HoldingsOtsuka Pharmaceutical

Otsuka Holdings Receives Award by the Commissioner of the Consumer Affairs Agency at FY2024 Award for Good Practices of Consumer-Oriented Management　- Recognized for Otsuka Pharmaceutical’s Longstanding Efforts to Prevent Heat Disorders-
February 18, 2025
Otsuka Foods

Otsuka Foods to Release Mannan Gohan with Glutinous Barley and Brown Rice Providing Approx. Five Times the Dietary Fiber of White Rice or Half the Recommended Daily Intake In Stores Across Japan on March 3, 2025
February 14, 2025
Otsuka Holdings

Otsuka Holdings Announces Personnel Changes
February 14, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Offer "Wellness Energy" at the Expo 2025 Osaka, Kansai, Japan Introducing a New Vision for “Shaping the Health of the Future”
February 13, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical Finalizes an Agreement with Fukuroi City on the Horizontal Recycling of PET Bottles Partnering with Its Factory to Promote a “Local Production and Local Recycling” Initiative for PET Bottles
February 7, 2025
Otsuka Holdings

Otsuka Group Selected for CDP Climate Change A List for a Third Consecutive Year
February 5, 2025
Otsuka Foods

Otsuka Foods to Release “Bon Curry NEO Ninniku Mashi Mashi: Hot” Enhanced Umami with Double the Garlic, Beef Sauteed in Red Wine, and a Rich Sauce In Stores across Japan from March 17, 2025
January 29, 2025
Taiho Pharmaceutical

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy
January 23, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical Launches the “Conditioning Supporter Training Program” Encouraging the Practice of Self-Conditioning
January 21, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical Releases the Total Conditioning Handbook for Well-Being to Support Life Performance
January 14, 2025
Otsuka Pharmaceutical

MIREVO, the first neuropsychological testing program in Japan to support dementia treatment, now available
January 10, 2025
Otsuka Pharmaceutical

Otsuka Announces FDA Plans to Host an Advisory Committee Meeting to Discuss the sNDA for Brexpiprazole in Combination with Sertraline for the Treatment of Adults with Post-Traumatic Stress Disorder (PTSD)
January 6, 2025
Otsuka Pharmaceutical

European Medicines Agency Commences Review of Donidalorsen in Hereditary Angioedema
December 23, 2024
Otsuka Foods

Otsuka Foods to Revise Prices of Some Products New Prices to Take Effect with Deliveries as of March 1, 2025
December 19, 2024
Otsuka Pharmaceutical

Detailed Findings in JAMA Psychiatry Show Otsuka and Lundbeck’s Phase 3 Trial of Brexpiprazole in Combination with Sertraline Significantly Improved Symptoms of Post-Traumatic Stress Disorder (PTSD) in Adults
December 12, 2024
Otsuka Pharmaceutical

Otsuka and Jolly Good initiate the sale of FACEDUO Dementia Care Support VR
December 5, 2024
Otsuka Pharmaceutical

Otsuka Expanding Use of Environmentally Friendly, Reusable Temperature-Controlled Containers
November 27, 2024
Otsuka Pharmaceutical

Otsuka Pharmaceutical Launches POCARI SWEAT Basketball Dream Project to Promote Sports and International Exchanges
November 26, 2024
Otsuka Pharmaceutical

Otsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia

Otsuka Group News

First 30 results